Previous studies provide evidence that AD and allergic asthma might share related drivers -i.e., IL-4 and IL-13- and that both conditions may benefit from a common therapeutic inhibition of these Th2 cytokines with dupilumab (21). Here, IL13 is linked to Alzheimer disease.